Share chart FibroGen
Extended chart
Simple chart
About FibroGen
FibroGen, Inc.- научная фармацевтическая компания, специализирующаяся на открытии, разработке и коммерциализации новых терапевтических агентов для лечения серьезных медицинских заболеваний. Компания использует глобальный подход к разработке и коммерциализации своих продуктов.Main settings
| IPO date | 2014-11-14 |
|---|---|
| ISIN | US31572Q8087 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | link |
| Цена ао | 0.33 |
| Change price per day: | 0% (0.33) |
|---|---|
| Change price per week: | +5.23% (0.3136) |
| Change price per month: | +3.13% (0.32) |
| Change price per 3 month: | -43.12% (0.5802) |
| Change price per half year: | -14.86% (0.3876) |
| Change price per year: | -74.62% (1.3) |
| Change price per 3 year: | -96.7% (9.99) |
| Change price per 5 year: | -99.19% (40.9) |
| Change price per 10 year: | -98.48% (21.77) |
| Change price per year to date: | -33.81% (0.4986) |
Grade
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
Insider trading
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| PRIMECAP Management Company | 14 471 928 | 14.65 |
| Armistice Capital, LLC | 9 764 000 | 9.89 |
| Blackrock Inc. | 7 205 300 | 7.29 |
| Vanguard Group Inc | 7 044 149 | 7.13 |
| Jacobs Levy Equity Management, Inc. | 2 489 506 | 2.52 |
| Acadian Asset Management. LLC | 2 468 928 | 2.5 |
| Citadel Advisors Llc | 2 390 681 | 2.42 |
| Assenagon Asset Management S.A. | 2 226 857 | 2.25 |
| Two Sigma Investments, LP | 2 101 283 | 2.13 |
| Geode Capital Management, LLC | 2 018 281 | 2.04 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Thane Wettig | CEO & Director | 807.35k | 1965 (60 years) |
| Dr. Barry A. Berkowitz Ph.D. | Founder | N/A | |
| Dr. John J. Hunter Ph.D. | Chief Scientific Officer | N/A | 1963 (62 years) |
| Ms. Christine L. Chung | Senior Vice President of China Operations | 1.27M | 1968 (57 years) |
| Mr. Michael D. Lowenstein J.D., Ph.D. | Chief Legal Officer | N/A | |
| Ms. Tricia Stewart | Chief People Officer | N/A | |
| Mr. Kirk A. Christoffersen MBA | Chief Business Officer | N/A | 1969 (56 years) |
| Dr. Rahul Rajan Kaushik Ph.D. | Senior Vice President of Pharmaceutical Development, Technical Operations & Manufacturing | N/A | |
| David DeLucia | Vice President of Corporate FP&A and Investor Relations | N/A | |
| Mr. Juan Graham | Senior VP & CFO | 1976 (49 years) |
About company
Address: United States, San Francisco, 409 Illinois Street - Open in google maps, Open in yandex maps
Website: https://www.fibrogen.com
Website: https://www.fibrogen.com
